SCHEMBL2435888

SCHEMBL2435888

CCN(CC)c1ccc2c(=O)c3ccc(N)cc3[nH]c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.53
ALDH1A1 P00352 7/20 0.47
L3MBTL1 Q9Y468 5/20 0.47
TDP1 Q9NUW8 4/20 0.47
MAPK1 P28482 3/20 0.47
CYP3A4 P08684 3/20 0.47
PSMD14 O00487 1/20 0.47
TSHR P16473 1/20 0.47
RECQL P46063 1/20 0.47
GFER P55789 1/20 0.47
HPGD P15428 4/20 0.44
MAPT P10636 4/20 0.44
KDM4E B2RXH2 4/20 0.44
HIF1A Q16665 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PARP1 P09874 1/20 0.44
KIF11 P52732 1/20 0.42
RET P07949 1/20 0.41
S100B P04271 1/20 0.41
MEN1 O00255 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31312450 0.80 PARP1 (0.62) ARALDH1A1TDP1GFERHPGD
SCHEMBL5332607 0.80 PARP1 (0.62) ARALDH1A1TDP1GFERHPGD
SCHEMBL12298197 0.78 MEN1 (0.51) ARALDH1A1L3MBTL1MAPTKDM4E
SCHEMBL5335867 0.74 PARP1 (0.59) ARALDH1A1TDP1GFERHPGD
SCHEMBL31473178 0.74 PARP1 (0.59) ARALDH1A1TDP1GFERHPGD
SCHEMBL29402764 0.74 AR (0.69) ARALDH1A1L3MBTL1MAPK1CYP3A4
SCHEMBL22501754 0.74 AR (0.69) ARALDH1A1L3MBTL1MAPK1CYP3A4
SCHEMBL3875172 0.73 KIF11 (0.47) ARALDH1A1L3MBTL1TDP1MAPK1
SCHEMBL6325907 0.73 CDK4 (0.69) ARALDH1A1TDP1HPGDKDM4E
SCHEMBL28407136 0.70 AR (1.00) AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8951938-B2 Combinatorial rosamine library to detect cell-state switching NEW YORK UNIVERSITY (US) 2015-02-10 US disclosed
US-8951938-B2 Combinatorial rosamine library to detect cell-state switching NEW YORK UNIVERSITY (US) 2015-02-10 US disclosed
US-8951938-B2 Combinatorial rosamine library to detect cell-state switching NEW YORK UNIVERSITY (US) 2015-02-10 US disclosed
US-8026110-B2 For detecting and imaging cells; solid phase synthesis NEW YORK UNIVERSITY (US) 2011-09-27 US disclosed
US-8026110-B2 For detecting and imaging cells; solid phase synthesis NEW YORK UNIVERSITY (US) 2011-09-27 US disclosed
US-8026110-B2 For detecting and imaging cells; solid phase synthesis NEW YORK UNIVERSITY (US) 2011-09-27 US disclosed
US-20090227467-A1 COMBINATORIAL ROSAMINE LIBRARY TO DETECT CELL-STATE SWITCHING NEW YORK UNIVERSITY (US) 2009-09-10 US disclosed
US-20090227467-A1 COMBINATORIAL ROSAMINE LIBRARY TO DETECT CELL-STATE SWITCHING NEW YORK UNIVERSITY (US) 2009-09-10 US disclosed
US-20090227467-A1 COMBINATORIAL ROSAMINE LIBRARY TO DETECT CELL-STATE SWITCHING NEW YORK UNIVERSITY (US) 2009-09-10 US disclosed
US-20080124751-A1 COMBINATORIAL ROSAMINE LIBRARY AND USES THEREOF NEW YORK UNIVERSITY (US) 2008-05-29 US disclosed
US-20080124751-A1 COMBINATORIAL ROSAMINE LIBRARY AND USES THEREOF NEW YORK UNIVERSITY (US) 2008-05-29 US disclosed
US-20080124751-A1 COMBINATORIAL ROSAMINE LIBRARY AND USES THEREOF NEW YORK UNIVERSITY (US) 2008-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080124751-A1 COMBINATORIAL ROSAMINE LIBRARY AND USES THEREOF RXFP1, RXFP2, CX3CR1 AR 1801/4885ALDH1A1 91/4885L3MBTL1 3223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.